Biomerica Reports Q3 Fiscal 2023 Results
IRVINE, Calif., April 14, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq:BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced its fiscal third quarter and nine month results ended February 28, 2023.
Related news for (BMRA)
- Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
- MoBot alert highlights: NASDAQ: CYCU, NASDAQ: WHWK, NASDAQ: MIGI, NASDAQ: BMRA, NASDAQ: BIAF (10/16/25 08:00 AM)
- 24/7 Market News Snapshot 16 October, 2025 – BIOMERICA INC (NASDAQ:BMRA)
- United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
- MoBot alert highlights: NASDAQ: BTBD, NYSE: NBY, NASDAQ: BMRA, NASDAQ: LCFY, NASDAQ: AIHS (09/03/25 08:00 AM)
